本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Kura Oncology, Inc

11.30
-0.2600-2.25%
盤後11.440.1400+1.24%19:30 EDT
成交量:182.74萬
成交額:2,049.44萬
市值:10.03億
市盈率:-3.36
高:11.48
開:11.48
低:11.03
收:11.56
52周最高:13.90
52周最低:7.36
股本:8,877.44萬
流通股本:7,060.22萬
量比:1.00
換手率:2.59%
股息:- -
股息率:- -
每股收益(TTM):-3.3668
每股收益(LYR):-3.1784
淨資產收益率:-167.71%
總資產收益率:-31.30%
市淨率:20.71
市盈率(LYR):-3.56

資料載入中...

2025/02/28

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/28

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/27

重要事件披露

Form 8-K - Current report
2025/02/05

重要事件披露

Form 8-K - Current report
2025/01/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/15

重要事件披露

Form 8-K - Current report
2025/01/07

重要事件披露

Form 8-K - Current report
2024/12/20

重要事件披露

Form 8-K - Current report
2024/12/05

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/20

重要事件披露

Form 8-K - Current report
2024/11/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/15

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/15

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/07

重要事件披露

Form 8-K - Current report
2024/11/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]